PATH, Coalition for Access to NCD Medicines and Products
Advancing access and financing for NCD medicines and products | UNGA80 Event Action Report
Report
20 Oct 2025
21 Oct 2024
This document sets out WHO’s MNS advocacy priorities, outlining what needs to be advanced or changed, by WHO and through other stakeholders and mechanisms. It aims to support MNS stakeholders in various countries by providing a flexible approach that can be used to create tailored advocacy strategies that address their specific national contexts and needs.